Skip to main content
. 2019 Jul 11;63(4):328–336. doi: 10.20945/2359-3997000000159

Figure 1. Individual IGF-I levels, expressed as a percentage of the age-adjusted upper limit of normal (ULN) range, before (dark blue circles) and after (light blue circles) pegvisomant (PEGV) treatment in 109 Brazilian patients with acromegaly.

Figure 1